These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36321572)

  • 1. Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.
    Xie R; Chen S; Li F; Yang L; Yu B
    J Biochem Mol Toxicol; 2023 Feb; 37(2):e23251. PubMed ID: 36321572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.
    Al Jadani JM; Albadr NA; Alshammari GM; Almasri SA; Alfayez FF; Yahya MA
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of syringic acid in nonalcoholic fatty liver in rats through regulation of Nrf2/HO-1 signaling pathway.
    Zhang S; Zheng S; Li Y; Yang J; Mao X; Liu T; Zhang Q; Fu Z; Zhu X; Xu L
    J Biochem Mol Toxicol; 2024 Sep; 38(9):e23809. PubMed ID: 39148263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 5. Dimethyl fumarate reduces oxidative stress, inflammation and fat deposition by modulation of Nrf2, SREBP-1c and NF-κB signaling in HFD fed mice.
    Vanani AR; Kalantari H; Mahdavinia M; Rashno M; Khorsandi L; Khodayar MJ
    Life Sci; 2021 Oct; 283():119852. PubMed ID: 34332979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang Y; Hao J; Liu Z; Li Z; Teng L; Wang D
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
    Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
    Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electromagnetic fields ameliorate hepatic lipid accumulation and oxidative stress: potential role of CaMKKβ/AMPK/SREBP-1c and Nrf2 pathways.
    Zhai M; Zhang C; Cui J; Liu J; Li Y; Xie K; Luo E; Tang C
    Biomed Eng Online; 2023 May; 22(1):51. PubMed ID: 37217972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
    Zhang N; Qu Y; Qin B
    Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice.
    Zhu SY; Jiang N; Yang J; Tu J; Zhou Y; Xiao X; Dong Y
    Biomed Pharmacother; 2018 Apr; 100():191-197. PubMed ID: 29428667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
    Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
    Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease.
    Fan C; Ling-Hu A; Sun D; Gao W; Zhang C; Duan X; Li H; Tian W; Yu Q; Ke Z
    J Agric Food Chem; 2023 Dec; 71(50):20105-20117. PubMed ID: 38073108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
    Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.